Zoetis Inc (ZTS)
175.12
+0.48
(+0.28%)
USD |
NYSE |
Nov 15, 16:00
175.12
0.00 (0.00%)
After-Hours: 20:00
Zoetis Cash and Short Term Investments (Quarterly): 1.71B for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.71B |
| June 30, 2024 | 1.573B |
| March 31, 2024 | 1.973B |
| December 31, 2023 | 2.039B |
| September 30, 2023 | 1.751B |
| June 30, 2023 | 1.714B |
| March 31, 2023 | 2.105B |
| December 31, 2022 | 3.577B |
| September 30, 2022 | 2.503B |
| June 30, 2022 | 2.648B |
| March 31, 2022 | 3.135B |
| December 31, 2021 | 3.482B |
| September 30, 2021 | 3.274B |
| June 30, 2021 | 3.658B |
| March 31, 2021 | 3.602B |
| December 31, 2020 | 3.602B |
| September 30, 2020 | 3.654B |
| June 30, 2020 | 3.353B |
| March 31, 2020 | 1.95B |
| December 31, 2019 | 1.932B |
| September 30, 2019 | 1.823B |
| June 30, 2019 | 1.776B |
| March 31, 2019 | 1.793B |
| December 31, 2018 | 1.696B |
| September 30, 2018 | 1.391B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.558B |
| March 31, 2018 | 1.654B |
| December 31, 2017 | 1.564B |
| September 30, 2017 | 1.981B |
| June 30, 2017 | 705.00M |
| March 31, 2017 | 629.00M |
| December 31, 2016 | 727.00M |
| September 30, 2016 | 651.00M |
| June 30, 2016 | 658.00M |
| March 31, 2016 | 675.00M |
| December 31, 2015 | 1.154B |
| September 30, 2015 | 592.00M |
| June 30, 2015 | 544.00M |
| March 31, 2015 | 559.00M |
| December 31, 2014 | 882.00M |
| September 30, 2014 | 598.00M |
| June 30, 2014 | 578.00M |
| March 31, 2014 | 506.00M |
| December 31, 2013 | 610.00M |
| September 30, 2013 | 389.00M |
| June 30, 2013 | 369.00M |
| March 31, 2013 | 468.00M |
| December 31, 2012 | 317.00M |
| September 30, 2012 | 133.00M |
| June 30, 2012 | 106.00M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.573B
Minimum
Jun 2024
3.658B
Maximum
Jun 2021
2.662B
Average
2.576B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Pfizer Inc | 9.952B |
| Regeneron Pharmaceuticals Inc | 9.796B |
| Vertex Pharmaceuticals Inc | 6.524B |
| Alnylam Pharmaceuticals Inc | 2.780B |
| Biomarin Pharmaceutical Inc | 930.44M |